Skip to main content
. 2021 Oct 14;13:747686. doi: 10.3389/fnagi.2021.747686

TABLE 3.

Longitudinal associations of blood UA levels with the risk of MCI.

Blood UA (μmol/La) Model 1 Model 2 Model 3
HR (95% CI) HR (95% CI) HR (95% CI)
Cox proportional hazards model
Per 10 μmol/L increment 0.99 (0.98, 0.10) 0.99 (0.98, 1.00) 0.99 (0.97, 0.10)
Q1 Ref. Ref. Ref.
Q2 0.84 (0.66, 1.06) 0.84 (0.66, 1.07) 0.82 (0.64, 1.06)
Q3 0.81 (0.64, 1.04) 0.83 (0.65, 1.06) 0.73 (0.56, 0.95)
Q4 0.74 (0.57, 0.96) 0.75 (0.57, 0.98) 0.73 (0.55, 0.96)
P for  trend 0.022 0.036 0.013
Fine and Gray competing risks model b
Per 10 μmol/L increment 0.98 (0.97, 0.99) 0.98 (0.97, 0.99) 0.98 (0.97, 0.99)
Q1 Ref. Ref. Ref.
Q2 0.90 (0.71, 1.14) 0.89 (0.69, 1.14) 0.88 (0.68, 1.13)
Q3 0.89 (0.70, 1.13) 0.80 (0.62, 1.04) 0.79 (0.61, 1.02)
Q4 0.70 (0.54, 0.91) 0.67 (0.51, 0.88) 0.67 (0.51, 0.88)
P for  trend 0.014 0.018 0.003

UA, uric acid; HR, hazard, ratio; CI, confidence interval.

Model 1 adjusted for age, sex, and education; model 2 additionally adjusted for drinking, smoking, marital status, regular exercise, body mass index, central obesity, adequate medical service; model3 additionally adjusted for hypertension, diabetes mellitus, self-reported history of heart disease, and stroke and cardiovascular disease.

aThe cutoff values were 213.9, 265.0, and 320.9 μmol/L for women, and 252.0, 305.6, and 365.1 μmol/L for men.

bAdjusted for death as competing risk.